Unity Biotechnology announces results from ASPIRE Phase 2b study in DME
UNITY Biotechnology (UBX) announced topline results from the Phase 2b ASPIRE clinical trial of intravitreal UBX1325 in patients with diabetic ...
AFP on MSN6d
Europe Adapts To New Trump Era With Diplomatic Shifts
From Brussels to Paris to London and back to Brussels -- the frenzy of diplomacy sparked by US President Donald Trump's ...
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient populationUBX1325 was ...
SMA News Today4d
MDA 2025: Apitegromab safely improves SMA motor function
Data from the SAPPHIRE study formed the basis of Scholar Rock's U.S. Food and Drug Administration request to approve ...
St. Thomas Source6dOpinion
Op-Ed: The Stories We Inherit and the Stories We Become
Every March, the Virgin Islands celebrates its history and culture extensively. We come together to commemorate the people, ...
pipsc6d
AFS Group Sub-Groups
2025 Annual General Meeting 200 Rene-Levesque West and Montreal AFS Sub-Groups and Montreal Centre Branch ...
Microsoft5d
Microsoft Edge Features & Tips
Microsoft Edge is your AI-powered browser that helps you achieve more. With unique features like Copilot, Designer, Vertical tabs, Read Aloud, and VPN, Edge helps you save time, save money and protect ...
American Bar Association1d
ABA Groups
It's time to renew your membership and keep access to free CLE, valuable publications and more. Your membership has expired - last chance for uninterrupted access to free CLE and other benefits.